Mar 11, 2024
FDA Grants Orphan Drug and Pediatric Exclusivities for CRESEMBA® (isavuconazonium sulfate) for Invasive Aspergillosis and Invasive Mucormycosis in Children
Feb 22, 2024
Astellas Names Michael Petroutsas as Head of US Commercial
May 27, 2020
FDA Approves VESIcare LS(TM) (solifenacin succinate) Oral Suspension for Pediatric Patients
May 20, 2020
European Medicines Agency Accepts Astellas' Marketing Authorization Application for Roxadustat
Jan 08, 2020
U.S. FDA Approves Supplemental New Drug Application (sNDA) for Expanded Indication of MYCAMINE® (micafungin for injection) for the Treatment of Invasive Candidiasis in Pediatric Patients Less Than 4 Months of Age
Sep 30, 2019
Astellas Oncology Announces 2019 C3 Prize® Finalists
May 20, 2019
Astellas Oncology Announces C³ Prize® Call for Entries to Award $200,000 to the Best Ideas in Cancer Care Beyond Medicine
Mar 18, 2019
Astellas Launches PROGRAF® Granules (tacrolimus for oral suspension) in the U.S. for Pediatric Liver, Heart, and Kidney Transplant Patients
Feb 28, 2019
Astellas Announces Key Leadership Promotions and New Hire in Legal, IP and Immuno-Oncology
Nov 12, 2018
Astellas Appoints Eloiza Domingo-Snyder to Head of Diversity and Inclusion
Oct 04, 2018
Astellas Oncology Announces Grand Prize Winner of C3 Prize® at Union for International Cancer Control (UICC) World Cancer Congress
Sep 24, 2018
Astellas Receives Positive CHMP Opinion for XTANDI® (enzalutamide) for Adult Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer
Sep 21, 2018
Astellas Oncology Announces C3 Prize® Celebrity Partnership and Category Winners
Sep 14, 2018
Astellas Named a PM360 Trailblazer 2018 "Company of the Year"
Sep 12, 2018
Astellas Announces Launch of "What's Next Sweepstakes" with Laila Ali
Aug 23, 2018
Astellas Appoints Shontelle Dodson to Senior Vice President Health Systems
Jun 08, 2018
Astellas names Nahrin Marino to Vice President, Head of Ethics & Compliance Americas
Nov 01, 2017
Astellas Announces Leadership Changes in U.S. Health Systems Commercial Organization
Oct 30, 2017
Astellas Appoints Gary Thal, M.D., to Vice President, Specialty, Medical Affairs, Americas